Go Pro

PVH (PVH) Financials

PVH logo
$73.69 +1.99 (+2.78%)
Closing price 03:59 PM Eastern
Extended Trading
$73.53 -0.17 (-0.23%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for PVH

Annual Income Statements for PVH

This table shows PVH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2016 1/29/2017 2/4/2018 2/3/2019 2/2/2020 1/31/2021 1/30/2022 1/29/2023 2/4/2024 2/2/2025 2/1/2026
Net Income / (Loss) Attributable to Common Shareholders
572 549 538 746 417 -1,136 952 200 664 599 25
Consolidated Net Income / (Loss)
572 549 536 745 415 -1,138 952 200 664 599 25
Net Income / (Loss) Continuing Operations
572 549 536 745 415 -1,138 952 200 664 599 25
Total Pre-Tax Income
648 674 510 776 444 -1,193 973 388 841 706 151
Total Operating Income
744 734 646 892 559 -1,067 1,077 471 929 772 186
Total Gross Profit
4,162 4,370 4,894 5,308 5,388 3,777 5,324 5,123 5,363 5,143 5,149
Total Revenue
8,020 8,203 8,915 9,657 9,909 7,133 9,155 9,024 9,218 8,653 8,950
Operating Revenue
8,020 8,203 8,915 9,657 9,909 7,133 9,155 9,024 9,218 8,653 8,950
Total Cost of Revenue
3,859 3,833 4,020 4,349 4,521 3,356 3,831 3,901 3,855 3,510 3,802
Operating Cost of Revenue
3,859 3,833 4,020 4,349 4,521 3,356 3,831 3,901 3,855 3,510 3,802
Total Operating Expenses
3,418 3,637 4,248 4,417 4,830 4,844 4,247 4,703 4,480 4,392 4,963
Selling, General & Admin Expense
3,418 3,678 4,245 4,433 4,715 3,983 4,454 4,377 4,543 4,411 4,492
Other Operating Expenses / (Income)
- -41 3.00 -16 86 -76 -88 -92 -47 - -8.90
Impairment Charge
- - - 0.00 0.00 934 - 417 0.00 0.00 480
Other Special Charges / (Income)
- - - - 29 3.10 -119 0.00 -15 -20 0.00
Total Other Income / (Expense), net
-96 -59 -136 -116 -115 -126 -104 -32 -42 -45 -35
Interest Expense
117 137 152 121 120 126 109 90 99 90 94
Interest & Investment Income
21 6.00 16 4.70 5.30 -0.40 4.40 58 57 71 60
Income Tax Expense
75 126 -26 31 29 -56 21 188 177 107 126
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 -0.30 -1.70 -1.80 -2.20 -1.40 -0.30 0.00 0.00 0.00 0.00
Basic Earnings per Share
$6.95 $6.84 $6.93 $9.75 $5.63 ($15.96) $13.45 $3.05 $10.88 $10.69 $0.53
Weighted Average Basic Shares Outstanding
82.40M 80.20M 77.60M 76.50M 70.88M 71.17M 68.01M 62.71M 57.69M 52.64M 45.81M
Diluted Earnings per Share
$6.89 $6.79 $6.84 $9.65 $5.60 ($15.96) $13.25 $3.03 $10.76 $10.56 $0.52
Weighted Average Diluted Shares Outstanding
82.40M 80.20M 77.60M 76.50M 70.88M 71.17M 68.01M 62.71M 57.69M 52.64M 45.81M
Weighted Average Basic & Diluted Shares Outstanding
82.40M 80.20M 77.60M 76.50M 70.88M 71.17M 68.01M 62.71M 57.69M 52.64M 45.81M
Cash Dividends to Common per Share
$0.04 $0.15 $0.15 $0.15 $0.15 $0.04 $0.04 $0.15 $0.15 $0.15 $0.15

Quarterly Income Statements for PVH

This table shows PVH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 2/4/2024 5/5/2024 8/4/2024 11/3/2024 2/2/2025 5/4/2025 8/3/2025 11/2/2025 2/1/2026 5/3/2026 8/2/2026
Net Income / (Loss) Attributable to Common Shareholders
272 151 158 132 157 -45 224 4.20 -158 88 -103
Consolidated Net Income / (Loss)
272 151 158 132 157 -45 224 4.20 -158 88 -103
Net Income / (Loss) Continuing Operations
272 151 158 132 157 -45 224 4.20 -158 88 -103
Total Pre-Tax Income
337 187 155 167 197 -350 111 160 229 109 -203
Total Operating Income
357 205 174 183 210 -332 121 181 204 124 -204
Total Gross Profit
1,501 1,199 1,246 1,317 1,381 1,162 1,251 1,293 1,443 1,186 1,322
Total Revenue
2,490 1,952 2,074 2,255 2,372 1,984 2,167 2,294 2,505 2,025 2,097
Operating Revenue
2,490 1,952 2,074 2,255 2,372 1,984 2,167 2,294 2,505 2,025 2,097
Total Cost of Revenue
989 753 828 939 990 822 916 1,002 1,062 839 775
Operating Cost of Revenue
989 753 828 939 990 822 916 1,002 1,062 839 775
Total Operating Expenses
1,155 1,007 1,083 1,144 1,185 1,503 1,130 1,121 1,209 1,074 1,526
Selling, General & Admin Expense
1,216 1,017 1,083 1,154 1,157 1,024 1,129 1,121 1,218 1,074 1,113
Impairment Charge
- 0.00 0.00 0.00 - 480 0.00 0.00 - 0.00 439
Other Special Charges / (Income)
-15 -10 0.00 -9.50 - 0.00 0.00 0.00 - 0.00 -25
Total Other Income / (Expense), net
-9.10 -4.50 -8.20 -5.50 -0.20 -7.90 -9.80 -12 -4.50 -3.30 1.70
Interest Expense
24 23 23 23 21 22 26 23 23 23 22
Interest & Investment Income
15 19 15 18 21 16 16 13 15 20 25
Other Income / (Expense), net
- - - - - -1.00 - -1.00 - -0.80 -0.60
Income Tax Expense
65 36 -3.20 35 39 -305 -113 156 388 21 -100
Basic Earnings per Share
$4.51 $2.63 $2.83 $2.37 $2.86 ($0.88) $4.66 $0.09 ($3.34) $1.92 ($2.23)
Weighted Average Basic Shares Outstanding
57.69M 55.86M 55.81M 55.63M 52.64M 48.07M 48.12M 45.80M 45.81M 46.11M 46.14M
Diluted Earnings per Share
$4.46 $2.59 $2.80 $2.34 $2.83 ($0.88) $4.63 $0.09 ($3.32) $1.90 ($2.23)
Weighted Average Diluted Shares Outstanding
57.69M 55.86M 55.81M 55.63M 52.64M 48.07M 48.12M 45.80M 45.81M 46.11M 46.14M
Weighted Average Basic & Diluted Shares Outstanding
57.69M 55.86M 55.81M 55.63M 52.64M 48.07M 48.12M 45.80M 45.81M 46.11M 46.14M

Annual Cash Flow Statements for PVH

This table details how cash moves in and out of PVH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2016 1/29/2017 2/4/2018 2/3/2019 2/2/2020 1/31/2021 1/30/2022 1/29/2023 2/4/2024 2/2/2025 2/1/2026
Net Change in Cash & Equivalents
77 174 -236 -42 51 1,148 -409 -692 157 40 -47
Net Cash From Operating Activities
905 903 644 853 1,020 698 1,071 39 969 741 680
Net Cash From Continuing Operating Activities
905 903 644 853 1,020 698 1,071 39 969 741 680
Net Income / (Loss) Continuing Operations
572 549 536 745 415 -1,138 952 200 664 599 25
Consolidated Net Income / (Loss)
572 549 536 745 415 -1,138 952 200 664 599 25
Depreciation Expense
257 322 325 335 324 326 313 302 299 282 272
Non-Cash Adjustments To Reconcile Net Income
17 -100 23 52 288 1,009 -98 387 -49 25 480
Changes in Operating Assets and Liabilities, net
59 132 -239 -279 -6.90 500 -97 -849 56 -165 -97
Net Cash From Investing Activities
-322 -427 -403 -395 -506 -59 -45 -278 -85 -138 -140
Net Cash From Continuing Investing Activities
-322 -427 -403 -395 -506 -59 -45 -316 -88 -138 -140
Purchase of Property, Plant & Equipment
-264 -247 -358 -380 -345 -227 -268 -290 -245 -159 -142
Acquisitions
-78 -190 -54 -16 -220 -1.60 0.00 0.00 0.00 0.00 0.00
Purchase of Investments
- - - - - 0.00 0.00 -8.60 -4.70 -5.50 -12
Sale of Property, Plant & Equipment
0.00 17 3.40 0.00 59 0.00 0.00 0.00 0.00 9.50 0.00
Divestitures
- - - 0.00 0.00 169 0.00 0.00 160 7.50 2.50
Sale and/or Maturity of Investments
- - - - - 0.00 0.00 -18 1.50 9.50 11
Other Investing Activities, net
20 -7.60 6.30 - - 0.00 223 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-484 -305 -509 -479 -452 477 -1,399 -428 -722 -550 -606
Net Cash From Continuing Financing Activities
-484 -304 -509 -479 -452 477 -1,399 -428 -722 -550 -606
Repayment of Debt
-340 -946 -971 -162 -1,720 612 -1,041 -451 -155 -574 -513
Repurchase of Common Equity
-138 -322 -259 -325 -345 -130 -377 -419 -570 -525 -578
Payment of Dividends
-13 -12 -12 -12 -11 -2.70 -2.70 -10 -9.40 -8.60 -7.50
Issuance of Debt
0.00 961 702 0.00 1,628 0.00 0.00 456 0.00 553 494
Issuance of Common Equity
7.40 15 32 20 2.50 3.90 27 0.00 18 7.30 1.40
Other Financing Activities, net
- - -0.80 - -5.50 -5.50 -5.20 -4.70 -4.60 -3.90 -3.20
Effect of Exchange Rate Changes
-23 3.00 31 -21 -11 32 -37 -25 -5.60 -12 19

Quarterly Cash Flow Statements for PVH

This table details how cash moves in and out of PVH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 2/4/2024 5/5/2024 8/4/2024 11/3/2024 2/2/2025 5/4/2025 8/3/2025 11/2/2025 2/1/2026 5/3/2026 8/2/2026
Net Change in Cash & Equivalents
350 -331 234 -50 188 -557 58 -91 543 -109 373
Net Cash From Operating Activities
658 -67 292 29 487 -71 213 -45 583 -47 383
Net Cash From Continuing Operating Activities
658 -67 292 29 487 -71 213 -45 583 -47 383
Net Income / (Loss) Continuing Operations
272 151 158 132 157 -45 224 4.20 -158 88 -103
Consolidated Net Income / (Loss)
272 151 158 132 157 -45 224 4.20 -158 88 -103
Depreciation Expense
76 72 70 70 71 68 69 69 67 63 57
Non-Cash Adjustments To Reconcile Net Income
-25 -13 5.50 -7.90 40 481 1.70 1.00 -3.80 -1.30 416
Changes in Operating Assets and Liabilities, net
335 -278 59 -165 219 -575 -82 -119 679 -196 12
Net Cash From Investing Activities
80 -41 -31 -29 -37 -28 -31 -41 -40 -42 5.70
Net Cash From Continuing Investing Activities
77 -41 -31 -29 -37 -28 -31 -41 -40 -42 5.70
Purchase of Property, Plant & Equipment
-81 -39 -37 -40 -43 -27 -31 -41 -44 -40 -37
Purchase of Investments
-1.40 -2.50 -0.50 -1.10 -1.40 -4.30 -4.30 -0.90 -2.00 -3.70 -1.20
Sale of Property, Plant & Equipment
- 0.00 - - - 0.00 - - - 0.00 38
Sale and/or Maturity of Investments
0.20 0.10 3.80 0.50 5.10 0.50 4.50 0.20 5.70 0.90 5.70
Net Cash From Financing Activities
-391 -222 -29 -49 -250 -463 -131 -5.70 -6.50 -21 -13
Net Cash From Continuing Financing Activities
-391 -222 -29 -49 -250 -463 -131 -5.70 -6.50 -21 -13
Repayment of Debt
-147 -12 -2.90 -3.10 -2.80 -3.00 -503 -3.20 -3.30 -3.20 -461
Repurchase of Common Equity
-284 -214 -31 -35 -245 -572 -4.80 -0.20 -0.50 -15 -2.00
Payment of Dividends
-2.30 -2.20 -2.10 -2.10 -2.20 -1.90 -2.00 -1.80 -1.80 -1.80 -1.70
Issuance of Debt
25 0.00 - -8.30 - 115 379 - - 0.00 452
Other Financing Activities, net
-1.20 -1.10 -1.10 -0.90 -0.80 -0.90 -0.90 -0.50 -0.90 -0.70 -0.50
Effect of Exchange Rate Changes
3.10 -1.60 - -1.30 -11 5.30 6.30 0.90 6.40 0.40 -2.30

Annual Balance Sheets for PVH

This table presents PVH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2016 1/29/2017 2/4/2018 2/3/2019 2/2/2020 1/31/2021 1/30/2022 1/29/2023 2/4/2024 2/2/2025 2/1/2026
Total Assets
10,674 11,068 11,886 11,864 13,631 13,294 12,397 11,768 11,173 11,033 11,681
Total Current Assets
2,805 2,880 3,031 3,239 3,394 3,944 3,654 3,580 3,260 3,488 3,605
Cash & Equivalents
556 730 494 452 503 1,651 1,243 551 708 748 702
Accounts Receivable
686 641 696 804 765 667 765 945 807 876 1,018
Inventories, net
1,322 1,318 1,591 1,732 1,616 1,417 1,349 1,803 1,420 1,509 1,584
Prepaid Expenses
150 133 185 169 160 158 169 209 238 211 219
Other Current Assets
75 57 65 82 113 50 128 73 88 144 71
Other Current Nonoperating Assets
15 - - 0.00 237 0.00 0.00 - - 0.00 12
Plant, Property, & Equipment, net
745 760 900 985 1,027 943 906 904 863 741 673
Total Noncurrent Assets
7,125 7,428 7,955 7,641 9,210 8,407 7,837 7,284 7,051 6,805 7,403
Goodwill
3,219 3,470 3,835 3,671 3,678 2,954 2,829 2,359 2,322 2,260 2,022
Intangible Assets
3,646 3,610 3,727 3,569 3,481 3,518 3,307 3,250 3,097 3,021 3,096
Other Noncurrent Operating Assets
259 349 394 401 2,052 1,935 1,701 1,675 1,631 1,524 2,284
Total Liabilities & Shareholders' Equity
10,674 11,068 11,886 11,864 13,631 13,294 12,397 11,768 11,173 11,033 11,681
Total Liabilities
6,122 6,261 6,347 6,036 7,822 8,567 7,108 6,756 6,054 5,893 6,889
Total Current Liabilities
1,527 1,565 1,872 1,894 2,361 2,582 2,788 2,768 2,772 2,742 2,376
Short-Term Debt
163 19 20 13 63 41 46 158 578 511 13
Accounts Payable
636 683 890 924 883 1,124 1,221 1,327 1,073 1,151 1,147
Accrued Expenses
696 832 923 892 930 940 1,101 874 776 736 821
Current Deferred Revenue
32 31 39 65 65 56 45 54 56 55 49
Other Current Liabilities
- - - 0.00 364 421 375 354 289 289 347
Total Noncurrent Liabilities
4,594 4,697 4,476 4,142 5,460 5,984 4,321 3,988 3,283 3,151 4,513
Long-Term Debt
3,032 3,197 3,061 2,819 2,694 3,514 2,318 2,177 1,592 1,580 2,291
Other Noncurrent Operating Liabilities
1,563 1,499 1,414 1,322 2,767 2,471 2,003 1,811 1,691 1,571 2,221
Total Equity & Noncontrolling Interests
4,552 4,805 5,536 5,828 5,812 4,730 5,289 5,013 5,119 5,141 4,792
Total Preferred & Common Equity
4,552 4,805 5,536 5,828 5,812 4,730 5,289 5,013 5,119 5,141 4,792
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,552 4,805 5,536 5,828 5,812 4,730 5,289 5,013 5,119 5,141 4,792
Common Stock
2,906 2,950 3,026 3,103 3,161 3,216 3,286 3,332 3,402 3,463 3,554
Retained Earnings
2,561 3,098 3,625 4,350 4,753 3,613 4,563 4,753 5,407 5,997 6,015
Treasury Stock
-211 -533 -793 -1,117 -1,463 -1,580 -1,947 -2,359 -2,937 -3,463 -4,088
Accumulated Other Comprehensive Income / (Loss)
-704 -711 -322 -508 -640 -519 -613 -713 -754 -857 -689

Quarterly Balance Sheets for PVH

This table presents PVH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 4/30/2023 7/30/2023 10/29/2023 5/5/2024 8/4/2024 11/3/2024 5/4/2025 8/3/2025 11/2/2025 5/3/2026 8/2/2026
Total Assets
11,491 11,542 11,167 10,789 11,238 11,241 10,672 11,628 11,421 11,342 11,417
Total Current Assets
3,353 3,414 3,347 2,912 3,414 3,478 3,034 3,299 3,276 3,375 3,983
Cash & Equivalents
374 373 358 376 610 560 191 249 158 593 966
Accounts Receivable
928 910 1,063 835 907 999 873 919 1,120 919 942
Inventories, net
1,718 1,796 1,477 1,347 1,583 1,608 1,596 1,791 1,664 1,510 1,738
Prepaid Expenses
254 256 209 264 235 222 260 258 238 268 254
Other Current Assets
79 80 102 90 80 90 97 65 78 73 83
Other Current Nonoperating Assets
0.00 0.00 140 0.00 0.00 0.00 17 17 17 12 0.00
Plant, Property, & Equipment, net
886 876 848 825 807 787 720 695 669 639 620
Total Noncurrent Assets
7,252 7,252 6,972 7,052 7,016 6,976 6,919 7,633 7,477 7,327 6,814
Goodwill
2,358 2,355 2,287 2,315 2,334 2,327 1,950 1,987 1,982 2,009 1,548
Intangible Assets
3,231 3,232 3,076 3,090 3,091 3,079 3,047 3,069 3,063 3,090 3,067
Other Noncurrent Operating Assets
1,664 1,666 1,609 1,647 1,592 1,570 1,922 2,577 2,432 2,229 2,199
Total Liabilities & Shareholders' Equity
11,491 11,542 11,167 10,789 11,238 11,241 10,672 11,628 11,421 11,342 11,417
Total Liabilities
6,365 6,505 6,113 5,730 6,046 5,953 6,054 6,761 6,542 6,447 6,625
Total Current Liabilities
2,396 3,124 2,846 1,877 2,760 2,695 2,731 2,410 2,235 2,013 2,416
Short-Term Debt
129 704 683 12 519 511 627 13 13 13 12
Accounts Payable
1,063 1,243 999 863 1,201 1,137 991 1,288 1,042 907 1,299
Accrued Expenses
802 774 795 643 676 706 764 729 798 704 704
Current Deferred Revenue
60 74 48 55 61 47 54 51 43 50 53
Other Current Liabilities
342 329 320 304 303 293 294 330 340 340 349
Total Noncurrent Liabilities
3,969 3,381 3,267 3,852 3,286 3,258 3,324 4,351 4,307 4,434 4,209
Long-Term Debt
2,193 1,620 1,571 2,146 1,668 1,654 1,720 2,256 2,246 2,269 2,237
Other Noncurrent Operating Liabilities
1,776 1,762 1,696 1,706 1,618 1,604 1,604 2,095 2,061 2,165 1,972
Total Equity & Noncontrolling Interests
5,126 5,038 5,054 5,059 5,192 5,288 4,618 4,867 4,879 4,895 4,792
Total Preferred & Common Equity
5,126 5,038 5,054 5,059 5,192 5,288 4,618 4,867 4,879 4,895 4,792
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,126 5,038 5,054 5,059 5,192 5,288 4,618 4,867 4,879 4,895 4,792
Common Stock
3,345 3,360 3,372 3,419 3,436 3,448 3,325 3,341 3,547 3,566 3,579
Retained Earnings
4,887 4,979 5,138 5,554 5,712 5,840 5,949 6,173 6,173 6,100 5,997
Treasury Stock
-2,364 -2,577 -2,650 -3,150 -3,182 -3,213 -3,885 -3,890 -4,087 -4,102 -4,104
Accumulated Other Comprehensive Income / (Loss)
-742 -723 -805 -764 -775 -788 -770 -757 -754 -668 -679

Annual Metrics And Ratios for PVH

This table displays calculated financial ratios and metrics derived from PVH's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2016 1/29/2017 2/4/2018 2/3/2019 2/2/2020 1/31/2021 1/30/2022 1/29/2023 2/4/2024 2/2/2025 2/1/2026
DEI Shares Outstanding
- - - - - - - - - - 45,802,696.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 45,802,696.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.55
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.68% 2.28% 8.68% 8.32% 2.61% -28.02% 28.35% -1.43% 2.14% -6.13% 3.44%
EBITDA Growth
30.94% 12.52% -13.81% 26.30% -28.05% -184.00% 287.54% -44.45% 58.95% -14.09% -55.42%
EBIT Growth
43.06% 8.20% -19.72% 37.99% -37.34% -291.00% 200.92% -56.29% 97.32% -16.85% -75.07%
NOPAT Growth
12.78% -9.21% 13.73% 26.08% -38.98% -243.01% 241.10% -76.95% 201.61% -10.63% -95.25%
Net Income Growth
30.42% -4.14% -2.30% 38.89% -44.25% -374.03% 183.69% -78.95% 231.14% -9.81% -95.77%
EPS Growth
30.74% -1.45% 0.74% 41.08% -41.97% -385.00% 183.02% -77.13% 255.12% -1.86% -95.08%
Operating Cash Flow Growth
14.70% -0.28% -28.63% 32.33% 19.68% -31.62% 53.53% -96.34% 2,372.96% -23.57% -8.17%
Free Cash Flow Firm Growth
5.12% -47.51% -132.00% 603.70% 9.58% -40.27% 151.92% -111.34% 756.57% -20.77% -82.55%
Invested Capital Growth
-3.45% 1.64% 11.42% 1.02% -3.96% -15.89% -3.33% 6.05% -3.19% -1.48% -1.55%
Revenue Q/Q Growth
0.55% -0.06% 4.59% -0.15% 1.19% -6.69% 3.86% 0.66% 0.01% -1.35% 1.51%
EBITDA Q/Q Growth
21.33% 0.74% -2.22% 6.41% -1.77% -15.65% 16.04% 9.02% 5.04% -12.58% -2.18%
EBIT Q/Q Growth
29.37% -0.68% -3.54% 8.92% -2.85% -10.18% 22.49% 16.83% 6.84% -15.96% -3.18%
NOPAT Q/Q Growth
10.59% -11.78% 16.96% 4.88% -4.62% -10.18% 82.31% -58.44% 23.94% -15.44% -94.38%
Net Income Q/Q Growth
16.89% -5.79% 1.40% 7.28% -0.17% -23.41% 89.23% -55.71% 25.09% -16.07% -92.58%
EPS Q/Q Growth
17.18% -4.77% 1.33% 7.94% -34.66% 0.19% 91.20% -51.52% 25.85% -13.37% -92.20%
Operating Cash Flow Q/Q Growth
6.07% -17.52% 21.39% 14.60% 782.61% -62.87% 25.45% -81.54% 54.71% -18.77% 16.57%
Free Cash Flow Firm Q/Q Growth
-13.19% -37.02% -866.69% 89.35% 117.44% -57.72% 67.60% -128.17% 143.57% 8.66% -72.86%
Invested Capital Q/Q Growth
-4.57% -1.90% 1.18% -2.73% -8.29% -1.35% -1.98% 2.83% -3.39% -5.96% -8.33%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
51.89% 53.28% 54.90% 54.97% 54.38% 52.95% 58.16% 56.77% 58.18% 59.43% 57.53%
EBITDA Margin
12.48% 13.74% 10.89% 12.70% 8.91% -10.39% 15.19% 8.56% 13.32% 12.19% 5.12%
Operating Margin
9.28% 8.94% 7.25% 9.23% 5.64% -14.96% 11.76% 5.22% 10.08% 8.93% 2.08%
EBIT Margin
9.28% 9.81% 7.25% 9.23% 5.64% -14.96% 11.76% 5.22% 10.08% 8.93% 2.08%
Profit (Net Income) Margin
7.14% 6.69% 6.01% 7.71% 4.19% -15.95% 10.40% 2.22% 7.20% 6.92% 0.28%
Tax Burden Percent
88.40% 81.39% 105.08% 96.00% 93.49% 95.35% 97.87% 51.62% 78.91% 84.81% 16.72%
Interest Burden Percent
87.04% 83.76% 78.95% 86.98% 79.47% 111.80% 90.32% 82.47% 90.55% 91.38% 81.39%
Effective Tax Rate
11.60% 18.61% -5.08% 4.00% 6.51% 0.00% 2.13% 48.38% 21.09% 15.19% 83.28%
Return on Invested Capital (ROIC)
9.00% 8.25% 8.81% 10.48% 6.49% -10.29% 16.17% 3.68% 10.96% 10.03% 0.48%
ROIC Less NNEP Spread (ROIC-NNEP)
6.01% 6.36% 3.18% 5.99% 1.67% -29.99% 9.41% 0.75% 6.69% 6.00% 0.09%
Return on Net Nonoperating Assets (RNNOA)
3.83% 3.48% 1.56% 2.62% 0.64% -11.28% 2.83% 0.21% 2.14% 1.64% 0.03%
Return on Equity (ROE)
12.84% 11.73% 10.37% 13.10% 7.13% -21.57% 19.00% 3.89% 13.10% 11.67% 0.51%
Cash Return on Invested Capital (CROIC)
12.51% 6.63% -1.99% 9.47% 10.53% 6.97% 19.55% -2.19% 14.20% 11.52% 2.04%
Operating Return on Assets (OROA)
6.92% 7.40% 5.63% 7.51% 4.38% -7.93% 8.38% 3.90% 8.10% 6.96% 1.64%
Return on Assets (ROA)
5.33% 5.05% 4.67% 6.27% 3.26% -8.45% 7.41% 1.66% 5.79% 5.39% 0.22%
Return on Common Equity (ROCE)
12.84% 11.73% 10.36% 13.10% 7.13% -21.56% 18.99% 3.89% 13.10% 11.67% 0.51%
Return on Equity Simple (ROE_SIMPLE)
12.57% 11.42% 9.68% 12.78% 7.14% -24.05% 18.00% 4.00% 12.96% 11.64% 0.00%
Net Operating Profit after Tax (NOPAT)
658 597 679 856 522 -747 1,054 243 733 655 31
NOPAT Margin
8.20% 7.28% 7.62% 8.86% 5.27% -10.47% 11.51% 2.69% 7.95% 7.57% 0.35%
Net Nonoperating Expense Percent (NNEP)
3.00% 1.89% 5.63% 4.49% 4.82% 19.69% 6.76% 2.93% 4.27% 4.03% 0.39%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 3.31% 10.06% 9.06% 0.44%
Cost of Revenue to Revenue
48.11% 46.72% 45.10% 45.03% 45.62% 47.05% 41.84% 43.23% 41.82% 40.57% 42.48%
SG&A Expenses to Revenue
42.61% 44.84% 47.62% 45.90% 47.59% 55.85% 48.65% 48.51% 49.28% 50.98% 50.19%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
42.61% 44.33% 47.65% 45.74% 48.74% 67.91% 46.39% 52.11% 48.60% 51.06% 55.45%
Earnings before Interest and Taxes (EBIT)
744 805 646 892 559 -1,067 1,077 471 929 772 186
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,001 1,127 971 1,227 883 -741 1,390 772 1,227 1,055 458
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.31 1.48 2.08 1.40 1.09 1.28 1.23 1.11 1.41 0.97 0.60
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.74 0.86 1.29 0.85 0.64 0.85 0.71 0.62 0.78 0.58 0.32
Price to Earnings (P/E)
10.39 12.91 21.43 10.95 15.15 0.00 6.81 27.71 10.89 8.32 112.83
Dividend Yield
0.21% 0.17% 0.10% 0.14% 0.17% 0.18% 0.04% 0.17% 0.12% 0.17% 0.24%
Earnings Yield
9.63% 7.75% 4.67% 9.13% 6.60% 0.00% 14.69% 3.61% 9.18% 12.01% 0.89%
Enterprise Value to Invested Capital (EV/IC)
1.20 1.31 1.74 1.29 1.09 1.20 1.19 1.08 1.32 0.98 0.70
Enterprise Value to Revenue (EV/Rev)
1.07 1.17 1.58 1.09 0.87 1.11 0.83 0.81 0.94 0.73 0.50
Enterprise Value to EBITDA (EV/EBITDA)
8.57 8.50 14.53 8.61 9.72 0.00 5.47 9.50 7.08 6.00 9.73
Enterprise Value to EBIT (EV/EBIT)
11.54 11.89 21.84 11.84 15.35 0.00 7.06 15.59 9.35 8.19 23.98
Enterprise Value to NOPAT (EV/NOPAT)
13.05 16.04 20.78 12.33 16.42 0.00 7.21 30.19 11.85 9.66 143.40
Enterprise Value to Operating Cash Flow (EV/OCF)
9.48 10.61 21.91 12.38 8.41 11.38 7.10 187.16 8.96 8.54 6.55
Enterprise Value to Free Cash Flow (EV/FCFF)
9.39 19.96 0.00 13.65 10.13 15.69 5.96 0.00 9.15 8.41 33.95
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.70 0.67 0.56 0.49 0.47 0.75 0.45 0.47 0.42 0.41 0.48
Long-Term Debt to Equity
0.67 0.67 0.55 0.48 0.46 0.74 0.44 0.43 0.31 0.31 0.48
Financial Leverage
0.64 0.55 0.49 0.44 0.38 0.38 0.30 0.28 0.32 0.27 0.30
Leverage Ratio
2.41 2.32 2.22 2.09 2.19 2.55 2.56 2.35 2.26 2.16 2.29
Compound Leverage Factor
2.10 1.95 1.75 1.82 1.74 2.85 2.32 1.93 2.05 1.98 1.86
Debt to Total Capital
41.23% 40.10% 35.74% 32.70% 32.17% 42.89% 30.88% 31.78% 29.76% 28.91% 32.47%
Short-Term Debt to Total Capital
2.10% 0.24% 0.23% 0.15% 0.74% 0.50% 0.60% 2.15% 7.92% 7.06% 0.18%
Long-Term Debt to Total Capital
39.14% 39.86% 35.52% 32.56% 31.43% 42.39% 30.29% 29.63% 21.84% 21.85% 32.29%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.02% 0.00% 0.02% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
58.77% 59.90% 64.23% 67.29% 67.81% 57.07% 69.12% 68.22% 70.24% 71.09% 67.53%
Debt to EBITDA
3.19 2.85 3.17 2.31 3.12 -4.80 1.70 3.02 1.77 1.98 5.03
Net Debt to EBITDA
2.63 2.21 2.66 1.94 2.55 -2.57 0.81 2.31 1.19 1.27 3.50
Long-Term Debt to EBITDA
3.03 2.84 3.15 2.30 3.05 -4.74 1.67 2.82 1.30 1.50 5.00
Debt to NOPAT
4.86 5.39 4.54 3.31 5.28 -4.76 2.24 9.61 2.96 3.19 74.13
Net Debt to NOPAT
4.01 4.16 3.81 2.78 4.32 -2.55 1.06 7.34 1.99 2.05 51.57
Long-Term Debt to NOPAT
4.61 5.36 4.51 3.29 5.16 -4.70 2.20 8.96 2.17 2.41 73.71
Altman Z-Score
2.04 2.19 2.56 2.52 1.93 1.20 2.17 2.04 2.55 2.36 1.91
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.02% 0.02% 0.02% 0.05% 0.03% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.84 1.84 1.62 1.71 1.44 1.53 1.31 1.29 1.18 1.27 1.52
Quick Ratio
0.81 0.88 0.64 0.66 0.54 0.90 0.72 0.54 0.55 0.59 0.72
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
914 480 -153 773 847 506 1,275 -145 949 752 131
Operating Cash Flow to CapEx
343.10% 392.61% 181.62% 224.64% 357.00% 307.90% 399.85% 13.51% 396.16% 496.58% 479.15%
Free Cash Flow to Firm to Interest Expense
7.81 3.51 -1.01 6.40 7.06 4.03 11.74 -1.61 9.56 8.38 1.39
Operating Cash Flow to Interest Expense
7.74 6.60 4.23 7.06 8.50 5.56 9.86 0.44 9.76 8.25 7.22
Operating Cash Flow Less CapEx to Interest Expense
5.48 4.92 1.90 3.92 6.12 3.75 7.40 -2.80 7.30 6.59 5.72
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.75 0.75 0.78 0.81 0.78 0.53 0.71 0.75 0.80 0.78 0.79
Accounts Receivable Turnover
11.22 12.36 13.33 12.87 12.63 9.96 12.79 10.55 10.52 10.28 9.45
Inventory Turnover
2.99 2.90 2.76 2.62 2.70 2.21 2.77 2.48 2.39 2.40 2.46
Fixed Asset Turnover
10.91 10.90 10.74 10.25 9.85 7.24 9.90 9.97 10.44 10.79 12.66
Accounts Payable Turnover
6.42 5.81 5.11 4.79 5.00 3.34 3.27 3.06 3.21 3.16 3.31
Days Sales Outstanding (DSO)
32.52 29.53 27.39 28.35 28.90 36.63 28.55 34.59 34.70 35.51 38.62
Days Inventory Outstanding (DIO)
122.00 125.71 132.06 139.49 135.17 164.93 131.76 147.41 152.57 152.24 148.44
Days Payable Outstanding (DPO)
56.82 62.79 71.38 76.13 72.95 109.15 111.72 119.20 113.67 115.64 110.31
Cash Conversion Cycle (CCC)
97.70 92.45 88.07 91.71 91.11 92.42 48.58 62.80 73.59 72.11 76.76
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,175 7,293 8,125 8,208 7,883 6,630 6,410 6,797 6,581 6,483 6,383
Invested Capital Turnover
1.10 1.13 1.16 1.18 1.23 0.98 1.40 1.37 1.38 1.32 1.39
Increase / (Decrease) in Invested Capital
-256 117 833 83 -325 -1,253 -221 388 -217 -97 -100
Enterprise Value (EV)
8,582 9,574 14,112 10,556 8,579 7,940 7,603 7,337 8,687 6,325 4,458
Market Capitalization
5,944 7,087 11,523 8,176 6,323 6,033 6,482 5,552 7,225 4,982 2,855
Book Value per Share
$55.55 $60.61 $71.97 $76.95 $79.66 $66.53 $75.58 $79.10 $85.83 $92.40 $104.63
Tangible Book Value per Share
($28.23) ($28.71) ($26.32) ($18.64) ($18.46) ($24.50) ($12.11) ($9.41) ($5.04) ($2.53) ($7.11)
Total Capital
7,747 8,021 8,619 8,660 8,571 8,289 7,652 7,348 7,288 7,231 7,097
Total Debt
3,194 3,216 3,081 2,832 2,757 3,555 2,363 2,335 2,169 2,091 2,305
Total Long-Term Debt
3,032 3,197 3,061 2,819 2,694 3,514 2,318 2,177 1,592 1,580 2,291
Net Debt
2,638 2,486 2,587 2,380 2,254 1,903 1,121 1,784 1,462 1,343 1,603
Capital Expenditures (CapEx)
264 230 355 380 286 227 268 290 245 149 142
Debt-free, Cash-free Net Working Capital (DFCFNWC)
883 604 685 906 593 -249 -331 420 358 509 541
Debt-free Net Working Capital (DFNWC)
1,440 1,334 1,179 1,358 1,097 1,402 912 971 1,066 1,257 1,242
Net Working Capital (NWC)
1,277 1,315 1,159 1,345 1,033 1,361 866 813 488 746 1,229
Net Nonoperating Expense (NNE)
85 48 143 111 107 391 102 43 69 56 5.79
Net Nonoperating Obligations (NNO)
2,623 2,488 2,587 2,380 2,070 1,897 1,121 1,784 1,462 1,343 1,591
Total Depreciation and Amortization (D&A)
257 322 325 335 324 326 313 302 299 282 272
Debt-free, Cash-free Net Working Capital to Revenue
11.01% 7.36% 7.68% 9.38% 5.99% -3.49% -3.61% 4.66% 3.88% 5.88% 6.04%
Debt-free Net Working Capital to Revenue
17.95% 16.26% 13.22% 14.06% 11.07% 19.66% 9.96% 10.76% 11.56% 14.52% 13.88%
Net Working Capital to Revenue
15.93% 16.03% 13.00% 13.92% 10.43% 19.09% 9.46% 9.01% 5.30% 8.62% 13.73%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$6.95 $6.84 $6.93 $9.75 $5.63 ($15.96) $13.45 $3.05 $10.88 $10.69 $0.53
Adjusted Weighted Average Basic Shares Outstanding
81.28M 78.20M 76.99M 75.15M 70.88M 71.17M 68.01M 62.71M 57.69M 52.64M 45.81M
Adjusted Diluted Earnings per Share
$6.89 $6.79 $6.84 $9.65 $5.60 ($15.96) $13.25 $3.03 $10.76 $10.56 $0.52
Adjusted Weighted Average Diluted Shares Outstanding
81.28M 78.20M 76.99M 75.15M 70.88M 71.17M 68.01M 62.71M 57.69M 52.64M 45.81M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
81.28M 78.20M 76.99M 75.15M 70.88M 71.17M 68.01M 62.71M 57.69M 52.64M 45.81M
Normalized Net Operating Profit after Tax (NOPAT)
658 597 452 856 549 -91 938 458 721 638 466
Normalized NOPAT Margin
8.20% 7.28% 5.07% 8.86% 5.54% -1.28% 10.24% 5.08% 7.82% 7.38% 5.20%
Pre Tax Income Margin
8.07% 8.22% 5.72% 8.03% 4.48% -16.73% 10.63% 4.30% 9.12% 8.16% 1.69%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.36 5.89 4.24 7.38 4.66 -8.50 9.92 5.25 9.35 8.60 1.97
NOPAT to Interest Expense
5.62 4.37 4.46 7.09 4.35 -5.95 9.71 2.71 7.38 7.29 0.33
EBIT Less CapEx to Interest Expense
4.10 4.21 1.91 4.24 2.27 -10.31 7.45 2.02 6.89 6.94 0.47
NOPAT Less CapEx to Interest Expense
3.37 2.69 2.13 3.95 1.97 -7.76 7.24 -0.53 4.92 5.63 -1.18
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
2.18% 2.22% 2.22% 1.56% 2.72% -0.24% 0.28% 5.04% 1.42% 1.44% 29.64%
Augmented Payout Ratio
26.36% 60.93% 50.55% 45.23% 85.86% -11.67% 39.83% 213.92% 87.36% 89.12% 2,313.04%

Quarterly Metrics And Ratios for PVH

This table displays calculated financial ratios and metrics derived from PVH's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 2/4/2024 5/5/2024 8/4/2024 11/3/2024 2/2/2025 5/4/2025 8/3/2025 11/2/2025 2/1/2026 5/3/2026 8/2/2026
DEI Shares Outstanding
- - - - - - - - 45,802,696.00 45,811,528.00 46,108,092.00
DEI Adjusted Shares Outstanding
- - - - - - - - 45,802,696.00 45,811,528.00 46,108,092.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -3.46 1.92 -2.23
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.05% -9.55% -6.01% -4.56% -4.75% 1.62% 4.48% 1.74% 5.63% 2.09% -3.24%
EBITDA Growth
15.77% 2.25% 11.38% -17.11% -35.08% -195.78% -17.52% -1.42% -3.63% 170.09% -177.81%
EBIT Growth
20.01% 3.17% 21.35% -20.32% -41.10% -262.46% -23.92% -1.80% -2.90% 137.06% -269.34%
NOPAT Growth
92.52% 8.36% 57.39% -19.16% -41.60% -240.34% 51.30% -96.72% -183.75% 143.35% -158.62%
Net Income Growth
95.96% 11.32% 67.73% -18.38% -42.16% -129.59% 41.90% -96.82% -200.70% 296.43% -145.90%
EPS Growth
98.22% 21.03% 86.67% -12.03% -36.55% -133.98% 65.36% -96.15% -217.31% 315.91% -148.16%
Operating Cash Flow Growth
108.86% 11.54% 7.66% -75.15% -26.03% -7.05% -27.12% -255.05% 19.88% 34.87% 79.68%
Free Cash Flow Firm Growth
311.96% 398.41% 343.84% 375.94% -47.39% -137.40% -57.70% -202.96% -115.31% 291.53% 355.67%
Invested Capital Growth
-3.19% -3.31% -3.14% 1.21% -1.48% -1.21% 1.49% 1.00% -1.55% -2.75% -11.58%
Revenue Q/Q Growth
5.37% -21.61% 6.27% 8.72% 5.17% -16.36% 9.26% 5.86% 9.19% -19.16% 3.55%
EBITDA Q/Q Growth
41.80% -35.91% -12.09% 3.73% 11.08% -194.55% 175.71% 23.98% 8.59% -31.23% -179.31%
EBIT Q/Q Growth
55.31% -42.53% -15.21% 5.29% 14.80% -258.52% 139.71% 35.90% 13.52% -39.49% -265.91%
NOPAT Q/Q Growth
60.96% -42.45% 7.12% -18.52% 16.28% -238.29% 215.49% -98.24% -3,073.15% 171.58% -241.85%
Net Income Q/Q Growth
68.19% -44.30% 4.36% -16.52% 19.18% -128.50% 600.45% -98.13% -3,869.05% 155.59% -216.93%
EPS Q/Q Growth
67.67% -41.93% 8.11% -16.43% 20.94% -131.10% 626.14% -98.06% -3,788.89% 157.23% -217.37%
Operating Cash Flow Q/Q Growth
469.44% -110.14% 538.38% -90.18% 1,595.12% -114.68% 398.46% -120.88% 1,410.56% -107.97% 923.44%
Free Cash Flow Firm Q/Q Growth
2,330.57% -20.76% -0.75% -84.27% 325.31% -156.33% 212.25% -138.28% 36.76% 804.74% 127.92%
Invested Capital Q/Q Growth
-3.39% 3.96% -1.05% 1.84% -5.96% 4.24% 1.66% 1.35% -8.33% 2.96% -7.58%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
60.29% 61.41% 60.06% 58.38% 58.24% 58.57% 57.72% 56.35% 57.61% 58.57% 63.03%
EBITDA Margin
17.37% 14.20% 11.75% 11.21% 11.84% -13.38% 9.27% 10.86% 10.80% 9.19% -7.04%
Operating Margin
14.33% 10.51% 8.38% 8.12% 8.86% -16.75% 6.15% 7.88% 8.15% 6.14% -9.74%
EBIT Margin
14.33% 10.51% 8.38% 8.12% 8.86% -16.80% 6.10% 7.84% 8.15% 6.10% -9.77%
Profit (Net Income) Margin
10.92% 7.76% 7.62% 5.85% 6.63% -2.26% 10.35% 0.18% -6.32% 4.35% -4.91%
Tax Burden Percent
80.68% 80.79% 102.07% 78.98% 80.00% 12.81% 201.62% 2.62% -69.01% 81.11% 50.79%
Interest Burden Percent
94.40% 91.37% 89.02% 91.21% 93.48% 104.92% 84.05% 89.15% 112.40% 87.85% 98.88%
Effective Tax Rate
19.32% 19.21% -2.07% 21.02% 20.00% 0.00% -101.62% 97.38% 169.01% 18.89% 0.00%
Return on Invested Capital (ROIC)
15.94% 11.00% 11.04% 8.21% 9.39% -14.97% 15.95% 0.26% -7.82% 6.72% -9.40%
ROIC Less NNEP Spread (ROIC-NNEP)
14.94% 10.23% 9.94% 7.45% 8.61% -5.40% 13.47% 0.23% -9.01% 6.04% -6.96%
Return on Net Nonoperating Assets (RNNOA)
4.79% 3.75% 3.43% 2.42% 2.35% -2.19% 4.80% 0.08% -2.66% 2.43% -2.37%
Return on Equity (ROE)
20.72% 14.74% 14.47% 10.63% 11.75% -17.16% 20.75% 0.35% -10.48% 9.14% -11.77%
Cash Return on Invested Capital (CROIC)
14.20% 14.08% 14.95% 10.10% 11.52% 9.46% 9.19% 6.98% 2.04% 5.29% 9.49%
Operating Return on Assets (OROA)
11.52% 8.50% 6.54% 6.36% 6.91% -13.60% 4.69% 6.10% 6.42% 4.98% -7.57%
Return on Assets (ROA)
8.77% 6.27% 5.94% 4.58% 5.17% -1.83% 7.94% 0.14% -4.98% 3.55% -3.80%
Return on Common Equity (ROCE)
20.72% 14.74% 14.47% 10.63% 11.75% -17.16% 20.75% 0.35% -10.48% 9.14% -11.77%
Return on Equity Simple (ROE_SIMPLE)
0.00% 13.42% 14.31% 13.48% 0.00% 8.71% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
288 166 177 145 168 -233 269 4.74 -141 101 -143
NOPAT Margin
11.56% 8.49% 8.56% 6.41% 7.09% -11.72% 12.39% 0.21% -5.62% 4.98% -6.82%
Net Nonoperating Expense Percent (NNEP)
0.99% 0.77% 1.11% 0.76% 0.78% -9.58% 2.48% 0.03% 1.19% 0.67% -2.44%
Return On Investment Capital (ROIC_SIMPLE)
3.95% - - - 2.33% -3.34% 3.76% 0.07% -1.98% 1.40% -2.03%
Cost of Revenue to Revenue
39.71% 38.59% 39.94% 41.62% 41.76% 41.43% 42.29% 43.65% 42.39% 41.43% 36.97%
SG&A Expenses to Revenue
48.85% 52.12% 52.22% 51.17% 48.77% 51.62% 52.09% 48.86% 48.63% 53.05% 53.05%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
46.40% 51.58% 52.21% 50.73% 49.95% 75.79% 52.09% 48.86% 48.28% 53.05% 72.78%
Earnings before Interest and Taxes (EBIT)
357 205 174 183 210 -333 132 180 204 124 -205
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
433 277 244 253 281 -266 201 249 271 186 -148
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.41 1.29 1.02 1.04 0.97 0.80 0.70 0.77 0.60 0.86 0.83
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 22.60
Price to Revenue (P/Rev)
0.78 0.72 0.60 0.63 0.58 0.43 0.39 0.43 0.32 0.47 0.45
Price to Earnings (P/E)
10.89 9.62 7.13 7.70 8.32 9.19 7.32 11.05 112.83 26.54 0.00
Dividend Yield
0.12% 0.13% 0.16% 0.15% 0.17% 0.21% 0.21% 0.19% 0.24% 0.16% 0.17%
Earnings Yield
9.18% 10.40% 14.03% 12.98% 12.01% 10.89% 13.66% 9.05% 0.89% 3.77% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.32 1.21 1.02 1.03 0.98 0.87 0.79 0.84 0.70 0.90 0.87
Enterprise Value to Revenue (EV/Rev)
0.94 0.92 0.77 0.81 0.73 0.67 0.62 0.67 0.50 0.65 0.59
Enterprise Value to EBITDA (EV/EBITDA)
7.08 6.74 5.46 5.89 6.00 11.41 11.57 12.53 9.73 6.47 9.21
Enterprise Value to EBIT (EV/EBIT)
9.35 8.89 7.11 7.73 8.19 24.90 28.04 30.56 23.98 9.16 16.64
Enterprise Value to NOPAT (EV/NOPAT)
11.85 11.15 8.49 9.17 9.66 10.44 7.49 10.62 143.40 35.32 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
8.96 8.50 6.88 7.78 8.54 7.95 8.30 10.05 6.55 8.35 6.03
Enterprise Value to Free Cash Flow (EV/FCFF)
9.15 8.48 6.68 10.25 8.41 9.10 8.69 12.13 33.95 16.71 8.59
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.42 0.43 0.42 0.41 0.41 0.51 0.47 0.46 0.48 0.47 0.47
Long-Term Debt to Equity
0.31 0.42 0.32 0.31 0.31 0.37 0.46 0.46 0.48 0.46 0.47
Financial Leverage
0.32 0.37 0.34 0.33 0.27 0.41 0.36 0.36 0.30 0.40 0.34
Leverage Ratio
2.26 2.19 2.23 2.17 2.16 2.22 2.27 2.23 2.29 2.31 2.39
Compound Leverage Factor
2.14 2.00 1.98 1.98 2.02 2.33 1.91 1.99 2.57 2.03 2.36
Debt to Total Capital
29.76% 29.90% 29.64% 29.05% 28.91% 33.70% 31.80% 31.65% 32.47% 31.80% 31.93%
Short-Term Debt to Total Capital
7.92% 0.16% 7.04% 6.86% 7.06% 9.00% 0.18% 0.18% 0.18% 0.18% 0.16%
Long-Term Debt to Total Capital
21.84% 29.73% 22.61% 22.19% 21.85% 24.69% 31.62% 31.47% 32.29% 31.62% 31.77%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
70.24% 70.10% 70.36% 70.95% 71.09% 66.30% 68.20% 68.35% 67.53% 68.20% 68.07%
Debt to EBITDA
1.77 1.75 1.74 1.80 1.98 4.58 4.82 4.82 5.03 2.51 3.92
Net Debt to EBITDA
1.19 1.44 1.25 1.33 1.27 4.21 4.29 4.48 3.50 1.86 2.24
Long-Term Debt to EBITDA
1.30 1.74 1.33 1.37 1.50 3.35 4.79 4.80 5.00 2.49 3.90
Debt to NOPAT
2.96 2.89 2.70 2.80 3.19 4.19 3.12 4.09 74.13 13.69 -12.40
Net Debt to NOPAT
1.99 2.39 1.95 2.07 2.05 3.85 2.78 3.80 51.57 10.14 -7.07
Long-Term Debt to NOPAT
2.17 2.88 2.06 2.14 2.41 3.07 3.10 4.06 73.71 13.62 -12.34
Altman Z-Score
2.38 2.42 2.15 2.20 2.20 1.89 1.93 2.04 1.92 2.12 1.98
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.18 1.55 1.24 1.29 1.27 1.11 1.37 1.47 1.52 1.68 1.65
Quick Ratio
0.55 0.65 0.55 0.58 0.59 0.39 0.48 0.57 0.72 0.75 0.79
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
505 400 397 62 265 -150 168 -64 -41 286 653
Operating Cash Flow to CapEx
807.99% -171.91% 798.91% 71.75% 1,123.56% -267.42% 683.01% -109.61% 1,340.69% -117.72% 0.00%
Free Cash Flow to Firm to Interest Expense
21.20 17.16 17.40 2.71 12.82 -6.68 6.51 -2.77 -1.78 12.62 29.27
Operating Cash Flow to Interest Expense
27.63 -2.86 12.82 1.25 23.50 -3.19 8.26 -1.92 25.58 -2.05 17.17
Operating Cash Flow Less CapEx to Interest Expense
24.21 -4.53 11.22 -0.49 21.41 -4.38 7.05 -3.67 23.67 -3.79 17.22
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.80 0.81 0.78 0.78 0.78 0.81 0.77 0.78 0.79 0.82 0.77
Accounts Receivable Turnover
10.52 10.22 9.77 8.51 10.28 10.17 9.61 8.32 9.45 10.04 9.59
Inventory Turnover
2.39 2.41 2.13 2.27 2.40 2.43 2.17 2.28 2.46 2.46 2.08
Fixed Asset Turnover
10.44 10.54 10.55 10.73 10.79 11.24 11.69 12.11 12.66 13.23 13.57
Accounts Payable Turnover
3.21 3.84 2.94 3.28 3.16 3.86 2.95 3.42 3.31 4.02 2.84
Days Sales Outstanding (DSO)
34.70 35.71 37.34 42.90 35.51 35.89 37.97 43.87 38.62 36.36 38.06
Days Inventory Outstanding (DIO)
152.57 151.17 171.56 160.46 152.24 150.05 167.90 160.10 148.44 148.45 175.15
Days Payable Outstanding (DPO)
113.67 95.00 124.10 111.12 115.64 94.54 123.86 106.61 110.31 90.70 128.38
Cash Conversion Cycle (CCC)
73.59 91.88 84.80 92.23 72.11 91.41 82.01 97.36 76.76 94.12 84.83
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,581 6,841 6,769 6,894 6,483 6,758 6,870 6,963 6,383 6,572 6,074
Invested Capital Turnover
1.38 1.30 1.29 1.28 1.32 1.28 1.29 1.27 1.39 1.35 1.38
Increase / (Decrease) in Invested Capital
-217 -234 -219 82 -97 -83 101 69 -100 -186 -796
Enterprise Value (EV)
8,687 8,311 6,871 7,099 6,325 5,852 5,449 5,868 4,458 5,886 5,276
Market Capitalization
7,225 6,529 5,293 5,494 4,982 3,696 3,429 3,767 2,855 4,197 3,994
Book Value per Share
$85.83 $87.70 $92.95 $94.75 $92.40 $87.74 $101.23 $101.39 $104.63 $106.84 $103.93
Tangible Book Value per Share
($5.04) ($5.99) ($4.17) ($2.12) ($2.53) ($7.20) ($3.94) ($3.45) ($7.11) ($4.44) $3.83
Total Capital
7,288 7,217 7,379 7,454 7,231 6,966 7,135 7,138 7,097 7,177 7,040
Total Debt
2,169 2,158 2,187 2,165 2,091 2,347 2,269 2,259 2,305 2,282 2,248
Total Long-Term Debt
1,592 2,146 1,668 1,654 1,580 1,720 2,256 2,246 2,291 2,269 2,237
Net Debt
1,462 1,782 1,577 1,606 1,343 2,156 2,020 2,101 1,603 1,690 1,282
Capital Expenditures (CapEx)
81 39 37 40 43 27 31 41 44 40 -1.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
358 670 564 735 509 739 653 895 541 783 612
Debt-free Net Working Capital (DFNWC)
1,066 1,046 1,174 1,295 1,257 930 902 1,053 1,242 1,375 1,578
Net Working Capital (NWC)
488 1,035 654 784 746 303 889 1,041 1,229 1,362 1,567
Net Nonoperating Expense (NNE)
16 14 19 13 11 -188 44 0.54 17 13 -40
Net Nonoperating Obligations (NNO)
1,462 1,782 1,577 1,606 1,343 2,140 2,003 2,084 1,591 1,678 1,282
Total Depreciation and Amortization (D&A)
76 72 70 70 71 68 69 69 67 63 57
Debt-free, Cash-free Net Working Capital to Revenue
3.88% 7.44% 6.35% 8.38% 5.88% 8.51% 7.44% 10.15% 6.04% 8.70% 6.86%
Debt-free Net Working Capital to Revenue
11.56% 11.61% 13.22% 14.76% 14.52% 10.71% 10.27% 11.95% 13.88% 15.29% 17.69%
Net Working Capital to Revenue
5.30% 11.48% 7.37% 8.93% 8.62% 3.49% 10.13% 11.80% 13.73% 15.15% 17.56%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.51 $2.63 $2.83 $2.37 $2.86 ($0.88) $4.66 $0.09 ($3.34) $1.92 ($2.23)
Adjusted Weighted Average Basic Shares Outstanding
57.69M 55.86M 55.81M 55.63M 52.64M 48.07M 48.12M 45.80M 45.81M 46.11M 46.14M
Adjusted Diluted Earnings per Share
$4.46 $2.59 $2.80 $2.34 $2.83 ($0.88) $4.63 $0.09 ($3.32) $1.90 ($2.23)
Adjusted Weighted Average Diluted Shares Outstanding
57.69M 55.86M 55.81M 55.63M 52.64M 48.07M 48.12M 45.80M 45.81M 46.11M 46.14M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
57.69M 55.86M 55.81M 55.63M 52.64M 48.07M 48.12M 45.80M 45.81M 46.11M 46.14M
Normalized Net Operating Profit after Tax (NOPAT)
276 158 122 137 168 103 93 127 143 101 147
Normalized NOPAT Margin
11.07% 8.08% 5.87% 6.08% 7.09% 5.20% 4.30% 5.52% 5.70% 4.98% 6.99%
Pre Tax Income Margin
13.53% 9.60% 7.46% 7.41% 8.29% -17.62% 5.13% 6.99% 9.16% 5.36% -9.66%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
15.00 8.80 7.63 7.96 10.15 -14.88 5.13 7.75 8.95 5.44 -9.19
NOPAT to Interest Expense
12.10 7.11 7.78 6.29 8.12 -10.38 10.41 0.20 -6.18 4.44 -6.41
EBIT Less CapEx to Interest Expense
11.58 7.14 6.02 6.22 8.06 -16.07 3.92 6.00 7.04 3.70 -9.13
NOPAT Less CapEx to Interest Expense
8.68 5.45 6.18 4.55 6.03 -11.57 9.20 -1.55 -8.09 2.70 -6.36
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
1.42% 1.35% 1.20% 1.22% 1.44% 2.06% 1.75% 2.32% 29.64% 4.68% -4.20%
Augmented Payout Ratio
87.36% 116.19% 82.18% 80.28% 89.12% 221.55% 184.55% 243.46% 2,313.04% 17.58% -14.62%

Financials Breakdown Chart

Key Financial Trends

PVH’s latest quarter shows a sharp rebound in profitability versus the same period last year, but cash flow remains under pressure and the balance sheet still carries meaningful leverage and large non-current liabilities. In Q1 2026, revenue rose to $2.03 billion, while the company generated $88 million of net income, a big improvement from the prior-year quarter’s loss. However, operating cash flow was negative in the quarter, and cash on hand declined from the prior quarter. Over the last several years, PVH has shown an ability to swing between solid profitability and periods of margin stress, often driven by SG&A, restructuring/impairment items, and working-capital changes.

  • Q1 2026 net income improved to $88 million from a $44.8 million loss in Q1 2025, showing a meaningful earnings recovery.
  • Revenue in Q1 2026 increased year over year to $2.03 billion from $1.98 billion in Q1 2025.
  • Gross profit improved to $1.19 billion, with gross margin holding fairly steady versus recent quarters.
  • The company posted positive operating income of $124.3 million in Q1 2026, reversing a loss in the comparable prior-year quarter.
  • Q1 2026 included no impairment charge or special charges, which helped keep reported earnings cleaner than some prior periods.
  • Inventory remained elevated at $1.51 billion, suggesting working capital is still a key area to watch.
  • Goodwill and intangible assets remain large on the balance sheet, so future write-down risk is still something investors should monitor.
  • Q1 2026 operating cash flow was negative $46.5 million, compared with strong operating cash generation in Q4 2025.
  • Cash and equivalents fell to $592.5 million from $1.02 billion in Q4 2025, reflecting a weaker short-term liquidity picture.
  • Total debt remains significant, with $2.27 billion of long-term debt and $12.9 million of short-term debt at the end of Q1 2026.

Looking at the broader trend, PVH has been volatile but resilient. In fiscal 2025, the company moved from a weak Q1 into a much stronger Q2 and Q4, with Q4 2025 especially notable for $583.2 million of operating cash flow and $157.2 million of net income. That momentum carried into Q1 2026 on the income statement, but not yet on the cash flow statement. Investors should pay close attention to whether PVH can convert improved earnings into sustained cash generation.

One important positive trend is that diluted share counts have been relatively stable to slightly lower over time, helped by buybacks, which can support per-share earnings. On the other hand, PVH’s operating performance has been sensitive to cost control: SG&A has remained high as a percentage of sales, and earlier periods showed how quickly impairment or special charges can pressure profits. The company’s recent results suggest the turnaround is progressing, but it is not yet fully reflected in cash flow consistency.

Bottom line: PVH appears to be recovering on profitability, but investors should remain cautious until the company shows more consistent free cash flow, stronger cash balances, and continued debt management.

09/18/26 12:06 AM ETAI Generated. May Contain Errors.

PVH Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PVH's financial year ends in February. Their financial year 2026 ended on February 1, 2026.

PVH's net income appears to be on a downward trend, with a most recent value of $25.30 million in 2025, falling from $572.40 million in 2015. The previous period was $598.50 million in 2024. View PVH's forecast to see where analysts expect PVH to go next.

PVH's total operating income in 2025 was $185.90 million, based on the following breakdown:
  • Total Gross Profit: $5.15 billion
  • Total Operating Expenses: $4.96 billion

Over the last 10 years, PVH's total revenue changed from $8.02 billion in 2015 to $8.95 billion in 2025, a change of 11.6%.

PVH's total liabilities were at $6.89 billion at the end of 2025, a 16.9% increase from 2024, and a 12.5% increase since 2015.

In the past 10 years, PVH's cash and equivalents has ranged from $452 million in 2018 to $1.65 billion in 2020, and is currently $701.50 million as of their latest financial filing in 2025.

Over the last 10 years, PVH's book value per share changed from 55.55 in 2015 to 104.63 in 2025, a change of 88.3%.



Financial statements for NYSE:PVH last updated on 9/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners